Synthesis route attribution of highly toxic ethyl sesquimustard based on non-targeted screening strategy and GC-HRMS
Analytical Methods · 2026 · 18 (24) · 5141-5149
DOI: 10.1039/d6ay00005c ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Methods, 2026. Verfasst von Yiming Tian und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Criminal Investigation, People's Public Security University of China, Beijing, 100038, China. zlkk77@163.com. Hauptthemen laut MEDLINE: Gas Chromatography-Mass Spectrometry, Chemical Warfare Agents, Mustard Gas. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Synthesis route attribution enables accurate source tracing of Q and effective discrimination between distinct synthetic pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Criminal Investigation, People's Public Security University of China, Beijing, 100038, China. zlkk77@163.com.
- Academy of Military Medical Sciences, Beijing, 100850, China. ammswjf@163.com.
ORCID-Profile: Jianfeng Wu, Jianwei Xie
Zitieren
APA
Tian, Y., Gu, Y., Wu, J., Chen, J., Jiang, J., Liu, Y., You, W., Li, K., & Xie, J. (2026). Synthesis route attribution of highly toxic ethyl sesquimustard based on non-targeted screening strategy and GC-HRMS. Analytical Methods, 18(24), 5141-5149. https://doi.org/10.1039/d6ay00005c
Vancouver
Tian Y, Gu Y, Wu J, Chen J, Jiang J, Liu Y, et al. Synthesis route attribution of highly toxic ethyl sesquimustard based on non-targeted screening strategy and GC-HRMS. Analytical Methods. 2026;18(24):5141-5149. doi:10.1039/d6ay00005c
BibTeX
@article{Tian2026,
author = {Tian, Yiming and Gu, Yixin and Wu, Jianfeng and Chen, Jia and Jiang, Jinqiao and Liu, Yulong and You, Wei and Li, Kaikai and Xie, Jianwei},
title = {Synthesis route attribution of highly toxic ethyl sesquimustard based on non-targeted screening strategy and GC-HRMS},
journal = {Analytical Methods},
year = {2026},
volume = {18},
number = {24},
pages = {5141--5149},
doi = {10.1039/d6ay00005c}
}
EUVIMED